Deep Genomics
Business Services · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
661 University Ave Ste 480, Toronto, Ont...Phone Number
(647) 598-8879Website
www.deepgenomics.comRevenue
$21 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Deep Genomics
Deep Genomics is an innovative company that leverages artificial intelligence, RNA biology, and automation to revolutionize drug development for genetic conditions. Their AI platform facilitates the discovery of RNA therapies by untangling complex biological data and identifying novel therapeutic targets. Committed to addressing a vast array of genetic diseases, Deep Genomics aims to develop targeted treatments tailored to specific genetic causes. The company is focused on advancing the understanding of RNA biology and expanding the possibilities for effective therapeutic solutions on a global scale.Explore more
Deep Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Deep Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Deep Genomics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Deep Genomics
Product Launch: Get notified when Deep Genomics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Deep Genomics recently announced quarterly report
Funding: Get notified immidiatlly once Deep Genomics has new funding data
Check out if Deep Genomics is spiking on competitors!
Deep Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Deep Genomics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Deep Genomics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Deep Genomics
Compare insights from companies similar to Deep Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Deep Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Deep Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Deep Genomics.
Deep Genomics financials insights
Gather financial insights about Deep Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$3.8M
2017
Series A
$13M
2021
Series C
$180M
Deep Genomics Tech Stack
A closer look at the technologies used by Deep Genomics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Person-Based
Deep Genomics News & Media
Breakthrough Properties to Welcome Three Mission-Driven Biotech Companies to One Canal Development in the Heart of Cambridge
Leases with Deep Genomics, Larkspur Biosciences and Incendia Therapeutics Executed Upon Substantial Construction Completion, Anchoring Breakthrough's East Cambridge Waterfront Building BOSTON, May 22, 2024 /PRNewswire/ -- Breakthrough Properties, a leading global developer, owner, and...Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics
TORONTO--(BUSINESS WIRE)-- #AI--Deep Genomics introduces the most advanced AI foundation model for RNA disease mechanisms and candidate therapeutics.H|T: The Healthtech Times – Deep Genomics adds life sciences veteran, Papa loses major contracts
Plus: Digital health, health IT funding slumped in Q2, but some bright spots remain. The post H|T: The Healthtech Times – Deep Genomics adds life sciences veteran, Papa loses major contracts first appeared on BetaKit.Deep Genomics to Present at the 2023 Elevate Festival
TORONTO--(BUSINESS WIRE)-- #AI--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its founder and Chief Innovation Officer, Brendan Frey, Ph.D., F.R.S.C., will present at the 2023 Elevate Festival in Toronto on Tuesday, September 26, 2022, at 6:35 PM EST. Brendan’s remarks, titled Beacons of Hope: AI in Medicine will highlight recent advances in the use of Artificial Intelligence (AI) and deep learning for dr
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Deep Genomics
Sign Up For FreeTo access detailed company insights
Deep Genomics is an innovative company that leverages artificial intelligence, RNA biology, and automation to revolutionize drug development for genetic conditions. Their AI platform facilitates the discovery of RNA therapies by untangling complex biological data and identifying novel therapeutic targets. Committed to addressing a vast array of gen... Read More
